Clinical Trial

Resistance Training and Injection Treatment for Achilles Enthesopathy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated November 4, 2024 completion). Its status may not reflect the trial's current state.
Summary
Achilles enthesopathy is a common and often long-lasting injury among exercising individuals. Very little is known regarding the effect of different treatment strategies. The purpose of the study is to evaluate two treatment strategies for achilles enthesopathy: Resistance training and restricted loading + corticosteroid injection compared to resistance training and restricted loading + local anesthesia injection. 50 patients with achilles enthesopathy are randomly assigned to the two treatment groups in this double blinded RCT.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-01-15; most recent amendment 2024-08-09.
Status change: Recruiting → Active, Not Recruiting 2023-08-25
Status change: Not Yet Recruiting → Recruiting 2022-03-13
Trial Details
NCT Number NCT04232358
Lead Sponsor Bispebjerg Hospital
Conditions Achilles Entesopathy
Enrollment 50 participants
Start Date 2021-05-04
Primary Completion 2024-11-04 (estimated)
Study Completion 2025-05-04 (estimated)
Updated on ClinicalTrials.gov 2024-08-12